In the news...
Fabio Gratton Named a 2022 Red Jacket Honoree
September 2022 - The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.
How Listening Tech Disrupts Clinical Research to Create Patient-Centric Trials
May 2022 - Fabio Gratton, CEO and Co-Founder of InVibe, which was recently acquired by THREAD Research, discusses how patient voice listening technology is enhancing and disrupting clinical research by making it easier to collect and use patient responses. The result could be more patient-centric trials informed by the actual patient voice.
FDA draft guidance may turn diversity in clinical trials from nice-to-have into a must-have
May 2022 - To make increased diversity a reality, sponsors will need concrete plans to bring new participants into the fold — no easy task.
“It’s already difficult to recruit for clinical trials. It’s already difficult to bring medications to market. We already know all the stats about how many trials failed to recruit, and how many trials are delayed by years just because you can’t find the right patient. So, there is certainly going to be some apprehension,” Gratton says.
Social Impact Tech: Kathryn Ticknor Robinson of ‘inVibe Labs’ On How Their Technology Will Make An Important Positive Impact
April 11, 2022 -- … The simplicity of the idea is what, for me, is so powerful. What we’re doing here isn’t complicated: we’re essentially removing the typical friction that exists when people try to share their voices with large healthcare organizations. We’re removing the friction that keeps the decision-makers from listening to their key stakeholders. We’re removing the friction that can create static and noise and misunderstanding in those conversations. We’re making listening a standard by empowering people to communicate candidly and conveniently, making analysis effective through a hybrid of human expertise and machine learning technology, and making reporting actionable with visual, dynamic dashboards."
Market Research Innovator inVibe Joins Inc. 5000 List of Fastest Growing Companies in America for 4th Year in a Row, and Merges with THREAD
Costa Mesa, CA (August 16, 2022) – inVibe has had a busy year; for the fourth year in a row, joining the ranks of the Inc. 5000 list of fastest-growing private companies and merging with the decentralized clinical trial platform, THREAD. Earning the rank of #3,519 on the annual list, inVibe continues to revolutionize healthcare-focused market research.
How Giving A Voice To The Disenfranchised Improves Public Health For All
July 2022 -- Since prescription drugs are taken by more than 45% of African-American persons, 37% of Hispanic persons and 33% of Asian persons, it behooves the pharmaceutical industry to accommodate their distinct needs throughout the drug development process. The Center for Information and Study on Clinical Research Participation (CISCRP) has confirmed the disproportionate representation of underserved American communities in clinical trials, compelling the FDA to broaden eligibility criteria to better reflect real-world patient demographics and ensure their systematic inclusion.
The FDA weighs in on market research and drug developers are listening – especially to the underserved
June 2022 - A new era of FDA guidance
The foundational value of research for marketing goes back to the pioneering work of Daniel Starch in the early 1920s, when data collection, analysis, and reporting were systematized for the first time. Since then companies across most verticals have spent billions to gain an advantage through an improved understanding of their competitors and consumers. Within our own healthcare industry, market research designed to help brands better empower patients and professionals to make the best treatment choices has similarly become table stakes.
MedCity News: Hearing is believing in clinical trials
March 25, 2022 -- The direct recording and analysis of voice ensures that a more diverse range of patients is represented in clinical trials. This is crucial for effective therapeutic outcomes.
inVibe named a finalist for the 6th Annual SCOPE 2022 Participant Engagement Award — Recognizing Clinical Trial Recruitment and Retention Innovation
January 7, 2022 -- Market research trailblazer inVibe, a division of THREAD, was selected as a finalist in the sixth annual Participant Engagement Award (PEA) recognizing innovation in clinical trial recruitment and retention. Presented at the 2022 Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida, inVibe was one of five finalists, including entries from Merck, Guardant Health, Infuss Health, and Tryl
THREAD Acquires inVibe to Integrate Voice of the Participant and Broaden Clinical Trial Design and Research Capabilities
CARY, N.C. (January 12, 2022) — THREAD, a leading technology and service provider enabling electronic clinical outcome assessments (eCOA) and decentralized clinical trials (DCTs), today announced that it has acquired inVibe, the leading voice-powered research and insights technology solution for the life sciences and health care industry. THREAD’s addition of inVibe’s voice research technology and consulting services to its comprehensive decentralized research platform follows the company’s acquisition of Modus Outcomes in November 2021.
inVibe Labs Ranks Number 330 Fastest-Growing Company in North America on 2021 Deloitte Technology Fast 500™
inVibe Labs (https://www.invibe.co), a pioneer in the field of voice technology for market research, today announced it ranked 330 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 27th year. inVibe Labs grew 371% during the 2017-2020, three-year period.
Pharmaceutical Companies Integrate Patient Insights into the Drug Development Process
November 2, 2021 -- inVibe Labs, a pioneer in the field of voice technology for market research, and recently included on the Inc. 5000 list of fastest growing companies for the third year in a row, has successfully introduced TrialPulse, a technology platform that helps integrate patient insights within the drug development process. Built on the backbone of inVibe's Voice Research platform already used by hundreds of commercial life science teams, TrialPulse is an easy-to-deploy technology solution empowering pharmaceutical companies with vital patient insights during clinical development that can be deployed across any disease state, and readily scaled across an entire organization.
Market Research Innovator Staffs-Up for Another Year of Exponential Growth
October 7, 2021 -- inVibe Labs, a pioneer in the field of voice technology for market research, and recently included on the Inc. 5000 list of fastest growing companies for the third year in a row, announced key promotions to resource their significant growth.
Social Impact Tech: Fabio Gratton of inVibe Labs On How Their Technology Will Make An Important Positive Impact
Authority Magazine - September 2021
Fabio Gratton, Co-founder and CEO of inVibe Labs, named one of ten “2021 Innovators of the Year” by Xpectives.Health
August 2021 - The Xpectives.Health Innovator awards are designed to honor people who work in the world of consumer health marketing making products, properties, and services that help promote and improve marketing effectiveness.
Healthcare-focused Market Research Company inVibe Labs Joins Inc. 5000 List of Fastest Growing Companies in America for 3rd Year in a Row
Healthcare Insights Company Again Claims The Honor As A Member Of The Coveted Inc. 5000, Citing Three-year Sales Growth Of 371 Percent.
Why the Patient Voice Should Influence Drug Development - and How It Can
PM360 – July 2021
Transforming the Patient Experience Through the Digitization of Market Research
Med Ad News and PharmaLive – June 2021
inVibe Labs Earns Rank of 356 on 2019 Inc. 5000 List of Fastest Growing Companies in America
PHILADELPHIA, PA – August 14, 2019 – inVibe Labs, a market research innovator dedicated to changing the way life sciences and other industries listen to their customers, today announced it has earned a top spot on the prestigious Inc. 5000 list of fastest growing private companies. A three-year growth rate of 1,282 percent earned inVibe the rank of #356 on the annual list, and a berth in the coveted Inc. 500. The ranking is driven by the development and deployment of inVibe’s proprietary conversational analysis platform, which provides actionable insights from voice-based customer feedback and stories.
inVibe Labs Expands Customer Listening Expertise with Key Appointments in Research and Engineering
COSTA MESA, Calif., – Feb. 4, 2019 — In line with its continued growth, inVibe Labs, a market research innovator dedicated to changing the way healthcare organizations listen to their customers, today announced the appointments of Kathryn Ticknor as Head of Research, Mariana Posada as Research Manager, and Zach Rigotti as Software Engineer. These newly created roles expands inVibe's presence in Virginia, Philadelphia, and Los Angeles, respectively.
inVibe Doubles Down in Downtown Philly with Top Talent Hires
COSTA MESA, Calif., – August 14, 2018 — inVibe Labs, the healthcare industry’s leading market research innovator, has just expanded its Philadelphia-based team with the hiring of two healthcare industry veterans, Beth Baldys and Donna Wray. This significant investment, along with other recent hires in its West coast office, allows inVibe to better serve its fast-growing base in pharma and biotech.
/voice
/resources
/use-cases
- New Data Intelligence
- TrialPulse — Evaluation of Clinical Trial Recruitment Assets
- Concept / Message Testing
- Customer Journey Inflection Points
- Agency Pitch for New Business
- TrialPulse — DCT Design and Informed Consent
- Language of Disease
- Customer Stories
- Decision Drivers
- Market Trends
- TrialPulse — Disease Burden and Endpoint Selection
- HCP – Patient Communication
2024 inVibe - All Rights Reserved